At Quay Pharma we are committed to finding the best formation and dosage delivery solution for every product, whether it is a New Chemical Entity (NCE), classic drug substance or a live biotherapeutic, to give it the best possible chances of clinical and commercial success. To do this, we have an extensive portfolio of pharmaceutical technologies that allow us to develop formulations that present particular challenges.
Complementing our more traditional drug products, these allow us to develop novel medications that will be effective in key therapeutic areas, as well as introducing significant performance advantages over existing products.
Quay Pharma's Broad Technologies Include:
- Conventional dosage forms.
- Drug solubilisation and bioavailability enhancement.
- Controlled release and gastrointestinal targeting.
- Live biotherapeutics.